Current Assets
Accrued investment income
Moderna Accrued investment income decreased by 7.1% to $39.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 26.4%, from $53.00M to $39.00M. Over 5 years (FY 2020 to FY 2025), Accrued investment income shows an upward trend with a 36.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryProfitability
SignalHigher is better
VolatilityStable
First reportedQ4 2018
Last reportedQ1 2026May 1, 2026
How to read this metric
An increase reflects a growing or higher-yielding investment portfolio, while a decrease may signal lower yields or asset sales.
Detailed definition
This represents interest and dividends earned on the investment portfolio that have not yet been received in cash. It is...
Peer comparison
Standard for any company with a significant investment portfolio.
Metric ID:
fin_accrued_investment_incomeHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $27.00M | $36.00M | $57.00M | $54.00M | $61.00M | $69.00M | $62.00M | $52.00M | $59.00M | $62.00M | $56.00M | $50.00M | $59.00M | $53.00M | $47.00M | $40.00M | $42.00M | $39.00M |
| QoQ Change | — | +33.3% | +58.3% | -5.3% | +13.0% | +13.1% | -10.1% | -16.1% | +13.5% | +5.1% | -9.7% | -10.7% | +18.0% | -10.2% | -11.3% | -14.9% | +5.0% | -7.1% |
| YoY Change | — | — | — | — | +125.9% | +91.7% | +8.8% | -3.7% | -3.3% | -10.1% | -9.7% | -3.8% | +0.0% | -14.5% | -16.1% | -20.0% | -28.8% | -26.4% |
Range$27.00M – $69.00M
CAGR+9.0%
Avg YoY Growth+6.4%
Median YoY Growth-6.8%
Accrued investment income at Other Companies
Frequently Asked Questions
- What is Moderna's accrued investment income?
- Moderna (MRNA) reported accrued investment income of $39.00M in Q1 2026.
- How has Moderna's accrued investment income changed year-over-year?
- Moderna's accrued investment income decreased by 26.4% year-over-year, from $53.00M to $39.00M.
- What is the long-term trend for Moderna's accrued investment income?
- Over 5 years (2020 to 2025), Moderna's accrued investment income has grown at a 36.1% compound annual growth rate (CAGR), from $9.00M to $42.00M.
- What does accrued investment income mean?
- Investment earnings that have been generated but not yet paid out to the company.